The Orphan Drug Act was passed 25 years ago. But the challenge of actually getting rare disease drugs and therapies to patients still remains
Jun 1, 2008
By:
Humphrey Taylor
|
This time, powerful interest groups (like pharma) that sank the Clinton healthcare bill are on the side of change
May 1, 2008
By:
Porcher L. Taylor III, University of Richmond, David E. Kitchen, University of Richmond
|
Pharma can stand to win hearts, minds, and tax credits by launching an eco bandwagon
How to make sense of the growing diabetes market in Brazil, Russia, India, and China
Oct 1, 2007
By:
Charles Conrad Uy, Gerhard Symons
|
The first wealth is health, wrote American thinker Ralph Waldo Emerson. Indeed, history has taught us (even before Emerson) that health and wealth are inextricably linked—the more money one has, the healthier one is likely to be.
It's easy to imagine what a reformed healthcare system would look like. What's hard is figuring out when it will happen—and what will drive the change.
Oct 1, 2007
By:
Humphrey Taylor
|
As I work with pharma companies, I'm often asked "When will we get major reform of the healthcare system?" and "What will the reformed system look like?" And sometimes "How will we get there?" This is not the same as asking "How should we reform the system?" Or "What should a reformed system look like?"
Our healthcare system may be broken, but playing the blame game is not going to fix it. Remember that disease—not Big Pharma—is the enemy.
Jul 30, 2007
By:
Peter Pitts
|
The US healthcare system may be broken, as such sages as Michael Moore suggest, but it's not likely to be fixed as long as our domestic debate remains stuck on the cost of prescription drugs. Meanwhile, obesity and diabetes are becoming national epidemics. Talk about sicko.
A comparative-effectiveness board is coming. The wise will embrace the change.
Jul 3, 2007
By:
Humphrey Taylor
|
If pharma is seen as a genuine contributor to the policy debate on comparative effectiveness, it could influence funding, pricing, and coverage decisions
A revamped version of an old bill calling for drug importation is on the congressional runway. With bipartisan backing and red-hot Rahmed-up rhetoric, the legislation might just pass—and spell failure for the future of innovative drug development.
May 1, 2007
By:
Peter Pitts
|
In march, us rep. rahm "Mr. Television" Emanuel (D-IL) reintroduced legislation aimed at what he calls "driving down the price of prescription drugs." But the only thing such legislation would accomplish would be the "driving down" of pharmaceutical innovation.
Healthcare systems in the developed world are in crisis. A permanent one. And that's OK, Henny Penny.
May 1, 2007
By:
Humphrey Taylor
|
If I had a dollar for every time I heard the word crisis used to describe the healthcare system of one country or another, I would be rich. And with the '08 elections revving up, we can expect to hear a crisis chorus from many presidential and congressional candidates wise to the fact that healthcare often ranks as voters' No. 1 issue.
